Purchases and Sales Made in Q1 2021 in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT) during Q1 2021. The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 17, 2021
Q1 2021
|
Hrt Financial LP
New York, NY |
BUY
|
- |
11.6KNew |
$60.4K - $92.3K
|
11.6K
$28.2K
|
|
|
May 17, 2021
Q1 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
543New |
$2.82K - $4.32K
|
543
$1.32K
|
|
|
May 13, 2021
Q1 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
12New |
$62.4 - $95.4
|
12
$29.2
|
|
|
May 13, 2021
Q1 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Sep 07, 2021
Q1 2021
|
Newbridge Financial Services Group, Inc.
|
SELL
|
- |
-250Closed |
$1.3K - $1.99K
|
0
$0
|
|
|
May 17, 2021
Q1 2021
|
Maven Securities LTD
St Helier, Y9 |
SELL
|
- |
-11KClosed |
$57.2K - $87.5K
|
0
$0
|